Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Hinge Therapeutics logo — Hinge Therapeutics is an early-stage biopharmaceutical compa...

Hinge Therapeutics

Hinge Therapeutics is an early-stage biopharmaceutical company which focuses on developing therapies for unmet needs.

Founded 2017 United States Torrance, United States 4 employees Biotechnology, Health Care

General Information

Company Name Hinge Therapeutics
Founded Year 2017
Location United States Torrance, United States
Employees 4
Industries Biotechnology, Health Care
Social

BounceWatch is an independent company data service, not affiliated with Hinge Therapeutics. To contact Hinge Therapeutics, visit hingethera.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Hinge Therapeutics compare?

A PDF of Hinge Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Hinge Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Hinge Therapeutics

Hinge Therapeutics is an early-stage biopharmaceutical company based in Torrance, CA (main lab) and in Sunnyvale, CA (satellite lab). Their focus is on developing small-molecule and small peptide therapeutics against traditionally undruggable/challenging targets for unmet medical needs. The company's proprietary Hinge Drug Discovery Platform has generated several novel inactivators against targets traditionally targeted only by large molecules such as antibody and siRNA, or not targeted by any means. Hinge Therapeutics is working on targets in bleeding disorders (including Hemophilia A&B), immuno-oncology (immuno-suppression), solid tumors (targeting tumor microenvironment), and Alzheimer’s. Additionally, they are developing a proprietary multi-ion bioimager which enables functional measurement of their targets in real-time. Their integrated drug discovery platform enables fast drug design and validation against some of the most challenging targets and diseases in the biotechnology and healthcare industries. The company was founded in 2017. Currently, there is no available information about their last investment or the investors involved.

Business keywords: biopharmaceuticals, drug discovery, rare diseases, CNS disorders, oncology, bleeding disorders, undruggable targets, protein conformation, small-molecule therapeutics, peptide therapeutics, immuno-oncology, tumor microenvironment, Alzheimer's, functional measurement, biomarker imaging

No funding data available for Hinge Therapeutics yet.

Hinge Therapeutics Alternatives & Competitors

View All Alternatives
Hinge Therapeutics vs
Wren Therapeutics
Wren Therapeutics United Kingdom

Stopping the wave of neurodegeneration at its source

Venture round
34 employees
Biopharma, Biotechnology
Hinge Therapeutics vs
DELIVER Therapeutics, Inc.
DELIVER Therapeutics, Inc. United States

Applying high throughput screening technologies to deliver novel therapeutics

7 employees
Biopharma, Biotechnology
Hinge Therapeutics vs
Myrobalan Therapeutics
Myrobalan Therapeutics United States

Myro’s mission is to develop first-in-class and best-in-class small molecule drugs for CNS disorders...

Grant
27 employees
Biotechnology, Health Care
View all alternatives

FAQ About Hinge Therapeutics

Hinge Therapeutics is an early-stage biopharmaceutical company which focuses on developing therapies for unmet needs.
Hinge Therapeutics was founded in 2017.
Hinge Therapeutics is headquartered in Torrance, United States.
Hinge Therapeutics operates in Biotechnology and Health Care. Its work centres on biopharmaceuticals, drug discovery, rare diseases and CNS disorders.
Hinge Therapeutics has approximately 4 employees.
Top alternatives and competitors to Hinge Therapeutics include Wren Therapeutics, DELIVER Therapeutics, Inc., Myrobalan Therapeutics, Rgenta Therapeutics Inc., Tempest Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Hinge Therapeutics and Wren Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Hinge Therapeutics, https://bouncewatch.com/company/hinge-therapeutics, updated 27 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes